Latest Bupropion/naltrexone Stories
LA JOLLA, Calif., Dec.
SAN DIEGO, Nov. 10, 2014 /PRNewswire/ -- Orexigen(®) Therapeutics, Inc.
The FDA has approved the weight loss pill Contrave, a medication that will be used to treat obese adults in conjunction with a controlled diet and exercise.
- Patent Protection for NB32 for Treating Insulin Resistance - SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that the U.S.
SAN DIEGO, Feb. 6, 2014 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor conferences.
SAN DIEGO, Jan. 7, 2014 /PRNewswire/ -- Orexigen® Therapeutics, Inc.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.